跳至主要内容
临床试验/NCT05279482
NCT05279482已完成不适用

Comparison Between Standard Dose Methyl Prednisolone and Megadose Methyl Prednisolone as Regards Outcome in SARS.COV.2 Patients in Intensive Care Unit : Retrospective Study

Ain Shams University2 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2022年1月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
104
试验地点
2
主要终点
28 days mortality rate

研究概览

简要总结

aim of this study is to compare between standard dose methyl prednisolone and mega dose methyl prednisolone as regards outcome reflected by mortality rate, percentage of mechanically ventilated patients and icu length of stay of covid 19 patients admitted in intensive care unit.

详细描述

Retrospective study for comparison between standard dose methyl prednisolone and mega dose methyl prednisolone as regards outcome reflected by mortality rate ,percentage of mechanically ventilated patients and icu length of stay of covid 19 patients admitted in intensive care unit.

Previous studies suggested that cytokine release syndrome could be involved in the pathophysiology of critical SARS.COV.2 resulting in death so early suppression of cytokine storm may be lifesaving in critical patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • All icu admitted covid 19 patients with positive PCR, diagnosed by CT chest and needing oxygen therapy

排除标准

  • Not requiring oxygen therapy
  • Negative PCR
  • Uncontrolled blood sugar or DKA
  • Patients on long term steroids therapy

结局指标

主要结局

28 days mortality rate

时间窗: 1 month

observation for mortality rate in both groups

次要结局

  • mechanical ventilation and icu length of stay(up to 3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amr M Hilal Abdou

Assistant Professor

Ain Shams University

研究点 (2)

Loading locations...

相似试验